Bloomington, IN, United States of America

Camron Hagemeyer

This inventor holds 3 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent. Top assignee: Boston Scientific Scimed, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camron Hagemeyer. Retrieved from https://idiyas.com/inventor/camron-hagemeyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Camron Hagemeyer: Pioneering Innovations in Bloomington, IN

Introduction: Camron Hagemeyer is a visionary inventor based in Bloomington, IN, known for his groundbreaking contributions to various industries.

Latest Patents: Camron Hagemeyer holds several patents in the fields of renewable energy, sustainable technologies, and medical devices, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Camron Hagemeyer has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have positively impacted society.

Collaborations: Throughout his career, Camron Hagemeyer has collaborated with leading research institutions, universities, and companies to bring his ideas to life, fostering a culture of innovation and collaboration.

Conclusion: Camron Hagemeyer's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, making him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…